203 related articles for article (PubMed ID: 24473396)
1. Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.
Ilie M; Long E; Hofman V; Selva E; Bonnetaud C; Boyer J; Vénissac N; Sanfiorenzo C; Ferrua B; Marquette CH; Mouroux J; Hofman P
Br J Cancer; 2014 Mar; 110(5):1236-43. PubMed ID: 24473396
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial cells as a biomarker in non-small cell lung cancer patients: correlation with clinical outcome.
Najjar F; Alammar M; Bachour M; Al-Massarani G
Int J Biol Markers; 2014 Dec; 29(4):e337-44. PubMed ID: 25041783
[TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells and microparticles for prediction of tumor progression and outcomes in advanced non-small cell lung cancer.
Najjar F; Alammar M; Al-Massarani G; Almalla N; Aljapawe A; Ikhtiar A
Cancer Biomark; 2017 Sep; 20(3):333-343. PubMed ID: 28800312
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD.
Kratzer A; Chu HW; Salys J; Moumen Z; Leberl M; Bowler R; Cool C; Zamora M; Taraseviciene-Stewart L
J Pathol; 2013 Aug; 230(4):388-98. PubMed ID: 23649916
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).
García-Donas J; Leon LA; Esteban E; Vidal-Mendez MJ; Arranz JA; Garcia Del Muro X; Basterretxea L; González Del Alba A; Climent MA; Virizuela JA; Álvarez C; Sepúlveda J; Anido U; López C; Ortiz-Morales MJ; Pérez X; Rodriguez-Antona C; Rodriguez-Moreno JF; Hernando S; Castellano D
Eur Urol Focus; 2017 Oct; 3(4-5):430-436. PubMed ID: 28753791
[TBL] [Abstract][Full Text] [Related]
7. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
Ikeda S; Kato T; Ogura T; Sekine A; Oda T; Masuda N; Igawa S; Katono K; Otani S; Yamada K; Saito H; Kondo T; Hosomi Y; Nakahara Y; Nishikawa M; Utumi K; Misumi Y; Yamanaka T; Sakamaki K; Okamoto H
BMC Cancer; 2018 Mar; 18(1):241. PubMed ID: 29499653
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction.
Wang D; Duan H; Feng J; Xiang J; Feng L; Liu D; Chen X; Jing L; Liu Z; Zhang D; Hao H; Yan X
Theranostics; 2020; 10(1):231-246. PubMed ID: 31903117
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study.
Arrigo M; Truong QA; Onat D; Szymonifka J; Gayat E; Tolppanen H; Sadoune M; Demmer RT; Wong KY; Launay JM; Samuel JL; Cohen-Solal A; Januzzi JL; Singh JP; Colombo PC; Mebazaa A
Clin Chem; 2017 Jan; 63(1):386-393. PubMed ID: 28062630
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Circulating Cell-Free Mitochondrial DNA and Proinflammatory Cytokines in Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer.
Bulgakova O; Kausbekova A; Kussainova A; Kalibekov N; Serikbaiuly D; Bersimbaev R
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1927-1933. PubMed ID: 34181353
[TBL] [Abstract][Full Text] [Related]
12. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.
Ali AM; Ueno T; Tanaka S; Takada M; Ishiguro H; Abdellah AZ; Toi M
Eur J Cancer; 2011 Oct; 47(15):2265-72. PubMed ID: 21737256
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.
Dufies M; Nollet M; Ambrosetti D; Traboulsi W; Viotti J; Borchiellini D; Grépin R; Parola J; Giuliano S; Helley-Russick D; Bensalah K; Ravaud A; Bernhard JC; Schiappa R; Bardin N; Dignat-George F; Rioux-Leclercq N; Oudard S; Négrier S; Ferrero JM; Chamorey E; Blot-Chabaud M; Pagès G
Theranostics; 2018; 8(9):2447-2458. PubMed ID: 29721091
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
[TBL] [Abstract][Full Text] [Related]
15. On the origin of (CD105+) circulating endothelial cells.
Strijbos MH; Verhoef C; Gratama JW; Sleijfer S
Thromb Haemost; 2009 Aug; 102(2):347-51. PubMed ID: 19652886
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
[TBL] [Abstract][Full Text] [Related]
19. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.
Tseng CC; Wang CC; Hsiao CC; Lu HI; Leu S; Chang HC; Huang KT; Fang WF; Chen YM; Liu SF; Yang CT; Lin MC; Yip HK
Tumour Biol; 2016 Sep; 37(9):11873-11882. PubMed ID: 27059732
[TBL] [Abstract][Full Text] [Related]
20. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
